Please assess the completion status of the following clinical trial:

Trial Title: Mobile Insulin Titration Intervention

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Initiating long-acting insulin treatment or initiating the titration of long-acting insulin treatment~* Speaks English or Spanish~* Hemoglobin A1c \> or = 8%~* Able and willing to inject insulin~* Able and willing to provide informed consent~Exclusion Criteria:~* Short-acting insulin treatment~* Systemic glucocorticoids~* Sustained elevated serum creatinine \> or = 1.5 mg/dL for men and \> or = 1.4 mg/dL for women~* Hypoglycemia unawareness~* Type 1 diabetes

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Mobile Insulin Titration Intervention (Type: EXPERIMENTAL): Mobile Insulin Titration Intervention (MITI) arm patients will relay their fasting blood glucose levels to the study staff via text message. The patient will receive insulin titration instructions through a weekly phone call with a diabetes nurse.
- Current Best Practice (Type: NO_INTERVENTION): Current Best Practice (CBP) arm patients will be treated according to the current best practice of insulin titration. They will attend scheduled clinic visits during which the provider will review their blood glucose logs and provide insulin titration instructions.

Based on this trial design, predict the completion outcome and termination type (if applicable).